Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase 2/3 2

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 9Rectal Neoplasms 5Colorectal Neoplasms 5Colonic Neoplasms 4Neoplasm Metastasis 1Gastric Cancer Stage 1Colorectal Cancer Metastatic 1Adenocarcinoma 1

Interventions

Fluorouracil 72Leucovorin 71Oxaliplatin 47Irinotecan 31Capecitabine 24Bevacizumab 23Folfox protocol 20Cetuximab 15Chemotherapy, Adjuvant 13Celecoxib 7Aspirin 6Laparoscopy 5XELOX 4Panitumumab 4Neoadjuvant Therapy 4Levamisole 4dehydroftorafur 3Tegafur 3Surgical Procedures, Operative 3Observation 3Floxuridine 3vatalanib 2tislelizumab 2pertuzumab 2encorafenib 2atezolizumab 2Trastuzumab 2Standard of Care 2Semaxinib 2Selenium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Colonic Neoplasms × XELOX × Clear all
NCT02355379 2024-07-08

ADAGE

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
774 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00958737 2023-09-29

IDEA

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown
2,000 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04416854 2020-06-04

The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

Fudan University

Phase 3 Unknown
627 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02912052 2016-09-23

PEPCORLI

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡